NYSE:PACSHealthcare
Is PACS Group (PACS) Fairly Priced After Strong Q1 Results And New US$250 Million Buyback Program
PACS Group (PACS) has moved into focus after reporting strong first quarter 2026 results, raising full year earnings guidance, and unveiling a new US$250 million share repurchase program alongside ongoing acquisition plans.
See our latest analysis for PACS Group.
The recent earnings beat, higher adjusted EBITDA guidance and new US$250 million buyback have come after a sharp 1 year total shareholder return of about 2.5x, even as the share price return year to date is down 5.1% with near term...